Behavioral Neuroadaptation to Alcohol: From Glucocorticoids to Histone Acetylation by Nicole Mons & Daniel Beracochea
October 2016 | Volume 7 | Article 1651
Review
published: 06 October 2016
doi: 10.3389/fpsyt.2016.00165
Frontiers in Psychiatry | www.frontiersin.org
Edited by: 
Stefan Borgwardt, 
University of Basel, Switzerland
Reviewed by: 
Giovanni Martinotti, 
Università degli Studi “G. d’Annunzio” 







This article was submitted 
to Addictive Disorders, 






Mons N and Beracochea D (2016) 
Behavioral Neuroadaptation 
to Alcohol: From Glucocorticoids 
to Histone Acetylation. 
Front. Psychiatry 7:165. 
doi: 10.3389/fpsyt.2016.00165
Behavioral Neuroadaptation to 
Alcohol: From Glucocorticoids 
to Histone Acetylation
Nicole Mons* and Daniel Beracochea
CNRS UMR 5287, Institut des Neurosciences cognitives et intégratives d’Aquitaine, Nouvelle Université de Bordeaux, 
Pessac, France
A prime mechanism that contributes to the development and maintenance of alco-
holism is the dysregulation of the hypothalamic–pituitary–adrenal axis activity and 
the release of glucocorticoids (cortisol in humans and primates, corticosterone in 
rodents) from the adrenal glands. In the brain, sustained, local elevation of gluco-
corticoid concentration even long after cessation of chronic alcohol consumption 
compromises functional integrity of a circuit, including the prefrontal cortex (PFC), 
the hippocampus (HPC), and the amygdala (AMG). These structures are implicated in 
learning and memory processes as well as in orchestrating neuroadaptive responses 
to stress and anxiety responses. Thus, potentiation of anxiety-related neuroadapta-
tion by alcohol is characterized by an abnormally AMG hyperactivity coupled with a 
hypofunction of the PFC and the HPC. This review describes research on molecular 
and epigenetic mechanisms by which alcohol causes distinct region-specific adaptive 
changes in gene expression patterns and ultimately leads to a variety of cognitive 
and behavioral impairments on prefrontal- and hippocampal-based tasks. Alcohol-
induced neuroadaptations involve the dysregulation of numerous signaling cascades, 
leading to long-term changes in transcriptional profiles of genes, through the actions 
of transcription factors such as [cAMP response element-binding protein (CREB)] and 
chromatin remodeling due to posttranslational modifications of histone proteins. We 
describe the role of prefrontal–HPC–AMG circuit in mediating the effects of acute and 
chronic alcohol on learning and memory, and region-specific molecular and epigenetic 
mechanisms involved in this process. This review first discusses the importance of 
brain region-specific dysregulation of glucocorticoid concentration in the development 
of alcohol dependence and describes how persistently increased glucocorticoid levels 
in PFC may be involved in mediating working memory impairments and neuroadaptive 
changes during withdrawal from chronic alcohol intake. It then highlights the role of 
cAMP–PKA–CREB signaling cascade and histone acetylation within the PFC and 
limbic structures in alcohol-induced anxiety and behavioral impairments, and how 
an understanding of functional alterations of these pathways might lead to better 
 treatments for neuropsychiatric disorders.
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iNTRODUCTiON
Alcoholism is a chronic, often relapsing brain disorder character-
ized by periods of sustained, compulsive alcohol intake, relying 
in part on allostatic changes within the prefrontal cortex (PFC) 
and limbic structures [i.e., the hippocampus (HPC) and the 
amygdala (AMG)] [for review, see Ref. (1)]. This circuit plays key 
roles in behavior and cognitive function as well as in orchestrat-
ing neuroadaptive responses to stress and anxiety. The transition 
from recreational to alcohol dependence and compulsive alcohol 
drinking takes place via neuroadaptive changes in the stress-
related neural circuits, caused partly by repeated cycles of alcohol 
intoxication and withdrawal (2, 3). A prime mechanism that con-
tributes to the development and maintenance of alcoholism is the 
dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis 
activity (4) and the release of glucocorticoids (cortisol in humans 
and primates, corticosterone in rodents) from the adrenal glands. 
Clinical and preclinical evidence in both humans (5–7) and 
rodents (4, 8, 9) have shown that acute and chronic alcohol con-
sumption, as well as withdrawal, markedly affects plasma gluco-
corticoid levels. The release of glucocorticoids can influence brain 
function by readily crossing the blood–brain barrier and exert 
effects through a dual glucocorticoid binding receptor system, 
i.e., the type I high affinity mineralocorticoid receptors (MRs) or 
the type II low affinity glucocorticoid receptors (GRs) (10), which 
act as ligand-dependent transcription factors to modulate target 
gene transcription. The MRs display a restricted expression in the 
brain, with highest densities in the HPC (11–13). The GRs are 
widely distributed throughout the brain (10, 14, 15) with a pre-
dominant expression in the three areas involved in learning and 
memory and particularly sensitive to the effects of stress, namely, 
the PFC, the dorsal HPC, and the AMG (16–18). Indeed, human 
studies of Cushing’s syndrome have shown that sustained cortisol 
elevation over the years compromises the integrity of the HPC–
PFC circuitry and thus influences the onset and/or the severity 
of cognitive decline in various tasks, including spatial, decision-
making and working memory processes (19–23). Further, sus-
tained, high local concentration of glucocorticoids is responsible 
for long-lasting cognitive impairments occurring several weeks 
after the cessation of alcohol in rodents (24, 25) and abstinent 
patients (26, 27). As to how elevation of glucocorticoids might 
be implicated in the enduring cellular, molecular, and behavioral 
changes, it has been suggested that neuroadaptation induced by 
alcohol exposure involves the dysregulation of numerous signal-
ing cascades, leading to long-term changes in transcriptional 
profiles of genes, through the actions of transcription factors 
such as [cAMP response element-binding protein (CREB)] and 
chromatin remodeling due to modifications of the posttransla-
tional properties of histone proteins [for review, see Ref. (28)]. In 
the following, we provide an overview of how transcriptional and 
histone acetylation changes in the PFC, the HPC, and the AMG 
play a central role in the glucocorticoid-dependent neuroadapta-
tion and behavioral deficits that occur during acute and chronic 
alcohol exposure. While this review focuses on aspects of how 
spatial and temporal changes in histone acetylation drive alcohol-
induced alterations in neural plasticity and behavior, it should 
be emphasized that other histone modifications marks, such as 
histone phosphorylation and histone lysine methylation, occur 
in parallel and are also involved in the long-term adaptations in 
neural function and behavioral responses to alcohol exposure.
BRAiN ReGiONAL GLUCOCORTiCOiD 
ReSPONSe TO CHRONiC ALCOHOL 
eXPOSURe
Surprisingly, little is known about the long-lasting neuroadap-
tive changes of glucocorticoids caused by prolonged alcohol 
consumption and withdrawal within neural circuits involved 
in learning and memory and emotional events and about their 
behavioral consequences. Studies, including our own, have 
shown that the initial phase of alcohol withdrawal period pro-
duces elevation in both circulating and brain glucocorticoids 
levels (29–31). Importantly, Little and colleagues (30) were first 
to show that during the initial phase of withdrawal from chronic 
(8  months in rats) alcohol consumption, rats and mice display 
an abnormal, exaggerated corticosterone level selectively in the 
medial PFC and the dorsal HPC. Strikingly, the authors found 
that withdrawal-associated excessive corticosterone response in 
the PFC persists for up to 2 months; therefore, long after, plasma 
corticosterone levels returned to baseline levels. In the PFC, the 
sustained elevation of corticosterone concentration was associ-
ated with enhanced GRs activation in mice undergoing a 2-week 
withdrawal period from chronic alcohol consumption (30). 
Further, administration of the GRs antagonist mifepristone or the 
dihydropyridine calcium channel nimodipine, given just prior 
to withdrawal from chronic alcohol exposure, not only reduced 
the rises in brain corticosterone but also prevented persistent 
memory deficits seen several weeks later in mice (24) or rats 
(32), suggesting that withdrawn-associated rise in glucocorticoid 
levels specifically within medial PFC may be an early index of 
maladaptive persistent behaviors in alcohol-dependent subjects. 
Indeed, chronic treatment with the GR antagonist mifepristone 
attenuated escalation of ethanol intake following intermittent 
ethanol vapor exposure (33) as well as the development of alcohol 
dependence and ultimately withdrawal-associated behavioral 
deficits (34). Endogenous glucocorticoids have been suggested to 
play an essential role in maintaining PFC-dependent cognitive 
functions, mainly via complex interaction with dopaminergic 
and glutamatergic receptors (35–37). Both human and animal 
studies have demonstrated that alcohol withdrawal impairs a 
variety of the cognitive functions during tests that require corti-
cal prefrontal processing (38–40). As regards, pharmacological 
(hydrocortisone administration) or pathological (Cushing’s 
disease) increase of cortisol was found to predict frontal cortex-
based cognitive impairments including alterations in executive 
processes and working memory dysfunction (19, 23, 41–43). 
Long-lasting deficits on tasks that rely on the PFC are also 
observed in rodent models in which chronic alcohol dependence 
is induced by chronic alcohol exposure or chronic intermittent 
ethanol that involves repeated cycles of exposure to alcohol 
vapors (44, 45). However, in addition to PFC dysfunction, there 
is evidence that a functional disconnection of brain network con-
nectivity between the (dorsomedial) PFC and the central nucleus 
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of the AMG may also contribute to the alcohol-induced working 
memory impairments in rats (46).
Recent work in our laboratory has employed in vivo micro-
dialysis in freely moving mice to investigate effects of chronic 
alcohol treatment and withdrawal (early and prolonged) periods 
on brain corticosterone concentrations by simultaneously meas-
uring time-course evolution of corticosterone concentration in 
the medial PFC and dorsal HPC seen before, during, and after 
completion of a working memory task in a T-maze (31, 47). This 
task is based on spontaneous alternation behavior, known to 
require intact connections between the two structures for suc-
cessful performance (48, 49). Specifically, alternation behavior 
is the innate tendency of rodents to alternate at each successive 
trial the choice of the goal arm over a series of trials run in a 
T-maze (except for the first trial). From trial to trial, accurate 
performance at a given trial (N) requires for subjects to be able 
to discriminate the specific target trial N − 1 from the interfering 
trial N − 2. Thus, the target information required for successful 
performance varies from trial to trial, so that the subject is not 
only required to temporarily keep specific information in short-
term storage but also reset it over successive runs. The resetting 
mechanisms and cognitive flexibility required to alternate over 
successive runs are major components of working memory 
processes. Working memory is a component of the sequential 
alternation task, since spontaneous alternation rates are depend-
ent on the length of the inter-trial delay interval and/or the place 
of the trial in the series. Indeed, repetitive testing constitutes 
a potent source of proactive interference. Thus, the sequential 
alternation procedure is relevant to assess delay-dependent 
working memory in mice (50–52). Using in vivo microdialysis 
in freely moving mice, we observed that early (1  week) and 
protracted (6  weeks) withdrawal periods from prolonged 
(6 months) alcohol exposure causes an exaggerated corticoster-
one rise in the medial PFC. In addition, withdrawn mice having 
abnormal corticosterone concentration in the PFC displayed 
impaired working memory performance, effects that were not 
observed in animals still submitted to chronic alcohol consump-
tion. Moreover, early and protracted withdrawal periods had 
no effect on the dynamic pattern of corticosterone response in 
the dorsal HPC, indicating that alcohol impacts glucocorticoid 
regulation in a brain region-specific fashion. During the 6-week 
withdrawal period, the degree of working memory impairment 
correlated with the magnitude of prefrontal corticosterone 
concentration, which is in accordance with the notion that there 
is a functional link between excessive corticosteroid signaling 
and PFC dysfunction (53–55). Many neuroimaging studies have 
indicated consistently that structural and functional deficits in 
PFC regulatory regions are associated with chronic alcoholism 
[for review, see Ref. (56)]. Another study using SPECT imaging 
showed that detoxified alcoholic patients who relapsed 2 months 
later displayed working memory deficits associated with low 
blood flow in the medial frontal lobe (57). Given the importance 
of frontal cortical regions in the modulation of AMG reactivity 
and the mediation of effective emotion regulation, weakened 
PFC function associated with a specific functional disconnec-
tion between the PFC and the AMG has been proposed as an 
early index of neuroadaptation in alcohol dependence that 
predicts PFC-dependent cognitive impairments observed dur-
ing abstinence (38, 39, 46).
Subsequently, we have studied whether local glucocorticoid 
blockade in the medial PFC would prevent the long-term deficits 
in working memory induced by protracted withdrawal from 
chronic alcohol consumption (31). Intraperitoneal administra-
tion of the corticosterone synthesis inhibitor metyrapone prior 
to testing prevented the withdrawal-associated working memory 
impairments, confirming the essential role of persistently 
increased glucocorticoid levels in behavioral impairments dur-
ing withdrawal from chronic alcohol intake. Similarly, a single 
bilateral infusion of spironolactone into the medial PFC that 
diminished MR activation and to a lesser extent of mifepristone 
that diminished GRs activation fully restored working memory 
function in withdrawn mice. In contrast, neither spironolactone 
nor mifepristone had any effect when infused into the dorsal 
HPC, thus highlighting the importance of glucocorticoids spe-
cific to the PFC in neural substrates mediating the prolonged, 
detrimental effects of alcohol on behavioral performance. These 
findings are reminiscent of data showing that elevated glucocorti-
coid levels, via either systemic injection of corticosterone or local 
infusion of the GRs agonist RU 28362 into the medial PFC shortly 
before testing, similarly impair working memory (55), while 
the GRs antagonist RU 38486 infused into the PFC can restore 
stress-induced deficits in executive function (58). Collectively, 
these data support the view that long-term adaptive behavioral 
effects of chronic alcohol exposure are mediated in large part 
through long-lasting glucocorticoid dysregulation within the 
PFC circuitry.
MOLeCULAR MeCHANiSMS 
UNDeRLYiNG ANXieTY-LiKe AND 
ALCOHOL-DRiNKiNG BeHAviORS: THe 
ROLe OF cAMP–PKA–CReB CASCADe
The transcription factor CREB is a key downstream target of a 
variety of kinases, including cAMP–protein kinase A (PKA), 
Ca2+/calmodulin-dependent kinase, and extracellular-regulated 
kinase/mitogen-associated protein kinase (ERK/MAPK) (59, 
60). The resulting activation/phosphorylation of CREB and 
recruitment of CREB-binding protein (CBP) along with other 
transcriptional components enables transcription of specific 
CREB target genes, including those implicated in long-term 
memory and plasticity as well as in the development of anxiety-
like and alcohol-drinking behaviors, such as the neuropeptide 
Y (NPY) and the brain-derived neurotrophic factor (BDNF) 
(61–64). There is mounting evidence to support a role for 
phosphorylated CREB (pCREB) through a PKA-dependent 
mechanism and downstream CREB target genes, in the adaptive 
changes and behavioral effects associated with acute and chronic 
alcohol exposure [for review, see Ref. (65–68)]. Acute and chronic 
ethanol exposures have long been known to modulate the vari-
ous steps of the cAMP-dependent pathways in the rodent brain 
and in other cell systems (69–71). Exposure to ethanol affects a 
cascade of events allowing for sustained translocation of PKA 
catalytic subunit into the nucleus (72), ultimately resulting in 
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long-lasting increased CREB activation/phosphorylation (73) 
and downstream expression of many target genes (74). In this 
context, abnormal PKA-dependent CREB functioning has been 
implicated in the molecular mechanisms of neuroplasticity that 
underlie alcoholism and alcohol drinking. There is evidence for 
a biphasic temporal effect of ethanol on cAMP–PKA-dependent 
signaling cascade with acute and prolonged exposure to ethanol 
potentiating (75) and decreasing (76, 77), respectively, adenylyl 
cyclase–cAMP–PKA activity in the cortex and HPC (78) in mice. 
Using a combination of genetic or pharmacological approaches, 
Drosophila and rodents studies have shown that maintaining 
integrity of the cAMP–PKA activity is central to establishing 
sensitivity to the sedative effect of ethanol as well as in modu-
lating ethanol consumption (79–81). Acute withdrawal (24  h) 
from chronic ethanol treatment produced a decrease in Ser133–
pCREB within specific neurocircuitry of the frontal, parietal, and 
piriform cortex in rats (82), suggesting the possibility that CREB-
dependent events in these cortical structures may be involved in 
the development of alcohol dependence. Among the mechanisms 
responsible for reduced pCREB and downregulation of cAMP-
dependent genes, chronic intermittent alcohol exposure has been 
shown to increase expression of the protein kinase inhibitor-α 
(PKI-α) in the PFC, nucleus accumbens, and AMG in Wistar rats 
(83). Given the wealth of data for the recruitment of the cAMP–
PKA signaling pathways upon acute ethanol exposure, it has been 
proposed that the increased PKI-α expression may be part of the 
adaptation of the cAMP–PKA pathway induced by intermittent 
alcohol exposure.
Investigations into the role of CREB in amygdaloid brain 
structures with regard to anxiety-like and alcohol-drinking 
behaviors have shown that CREB activity fluctuates depending 
on brain structures and alcohol “condition” (acute, chronic, or 
withdrawal). For instance, a series of studies by Pandey’s group 
conducted in the rat AMG clearly indicate a strong relationship 
between decreased CREB phosphorylation and high anxiety-
like responses associated with acute withdrawal from 2-week 
ethanol treatment (62, 82). Decreases in CREB phosphorylation 
and downstream cAMP-inducible genes, including NPY in the 
central and medial, but not the basolateral, nuclei of the AMG, 
have been associated with a predisposition to both anxiety-like 
and excessive alcohol-drinking behaviors in alcohol-preferring 
rats (60, 84–86). Restoring CREB function to optimal level or 
enhancing NPY signaling in the central AMG prevented the onset 
of anxiety-like behaviors (84, 87, 88), while alcohol-associated 
anxiety disorders can be mimicked by pharmacological blockade 
of PKA in ethanol-naïve-preferring rats or non-preferring rats 
(60, 84). Thus, anxiety-induced downregulation of CREB func-
tion in the AMG may constitute a critical neuroadaptation central 
to the development and maintenance of alcohol dependence. 
As regards, dysregulation of the PFC associated with a functional 
disconnection between the PFC and AMG central nucleus during 
abstinence and renewed access to alcohol has been implicated in 
long-lasting cognitive impairment and excessive alcohol drinking 
in rats (46).
Clinical evidence from alcohol-dependent patients also indi-
cates that acute and protracted withdrawal/abstinence is strongly 
associated with depressive-like behaviors, such as anhedonia.
The catecholamines dopamine and noradrenaline via the 
cAMP–PKA–CREB signaling cascade provide an essential 
modulatory influence on PFC-dependent behaviors produc-
ing an inverted “U-shaped” dose–response influence, whereby 
moderate levels improve PFC function while either too little or 
too much catecholamines lead to cognitive impairments [for 
review, see Ref. (89)]. A number of studies including work in our 
laboratory (51) have shown that blocking the cAMP–PKA–CREB 
signaling cascade via local infusion of Rp-cAMPS (a compound 
known to inhibit CREB phosphorylation) into the PFC prevents 
the impairing effect of stress or aging on working memory per-
formance, while drugs that increase cAMP–PKA signaling either 
by direct intra-PFC infusion of the cAMP analog Sp-cAMPS 
or dopamine D1 receptor agonist or i.p. administration of the 
phosphodiesterase (PDE) inhibitor Rolipram impair cognitive 
functions [for reviews, see Ref. (89–91)]. As mentioned above, 
we recently reported that consumption of an alcohol-containing 
liquid diet for 6 months followed by a 1-week withdrawal period 
produces working memory impairment in a T-maze spontaneous 
alternation task in mice, which persists for at least 6 weeks after 
the cessation of alcohol intake (31, 47). Moreover, withdrawn 
mice displaying impaired working memory performance were 
those that had the lowest pCREB level in the PFC along with a 
persistent rise of prefrontal corticosterone concentration. Because 
glucocorticoids in the PFC interact with β-adrenoceptor–cAMP/
PKA activity to influence working memory function (92), one 
route by which elevated glucocorticoid levels may impair PFC-
mediated cognitive function long after the cessation of alcohol 
exposure is by inhibiting the cAMP–PKA cascade. In this con-
text, growing evidence supports a central role for PDE, which 
is responsible for the breakdown of cAMP, in the regulation of 
alcohol drinking in rodents [for review, see Ref. (93)]. For exam-
ple, treatment with various PDE4 inhibitors, including rolipram, 
produces long-lasting reduction of alcohol intake and preference 
in C57BL/6J mice (94). Chronic rolipram treatment also results 
in sustained reduction of alcohol seeking and consumption in 
alcohol-preferring rats (95, 96). As mentioned earlier, mice 
subjected to 1- or 6-week alcohol withdrawal from chronic 
alcohol consumption exhibited working memory impairments 
accompanied by enhanced anxiety level (at 1 week only) as well 
as persistently elevated corticosterone and sustained decreased 
pCREB levels in the PFC. Intraperitoneal administration of 
the PDE4 inhibitor, rolipram, before working memory testing 
abolished these withdrawal-associated behavioral, endocrine, 
and neuronal alterations (31) – a finding consistent with other 
observation, which demonstrated that in rats, heightened anxiety 
during acute alcohol withdrawal was accompanied by elevated 
expression of Pde10a isoform mRNA levels in interconnected 
medial PFC–AMG circuit, which persisted in the AMG after 
protracted (6  weeks) alcohol withdrawal (97). Together, these 
observations strongly support further research with regard to 
isoform-specific PDE-selective inhibitors that are promising 
pharmacotherapy targets for alcohol use disorders.
As discussed above, long-term adaptive behavioral effects 
of chronic alcohol exposure are mediated in large part through 
long-lasting glucocorticoid dysregulation within the PFC but 
not the dorsal HPC. Confirming differential sensitivity of the 
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PFC and dorsal HPC to chronic alcohol-induced damage, recent 
work in our laboratory has shown that, unlike the PFC in which 
withdrawal from prolonged alcohol intake caused persistent 
working memory impairments along with sustained inhibition 
of the cAMP–PKA–CREB signaling cascade, both alcohol (unim-
paired) and alcohol withdrawal (impaired) mice display reduced 
levels of pCREB in the dorsal HPC (namely, the CA1 region), 
compared with water-drinking mice (31, 47). Furthermore, 
intraperitoneal administration of rolipram was able to correct the 
deficit in pCREB in the dorsal HPC but did not reverse working 
memory impairments in withdrawn animals (47). Together, these 
observations support the notion that disruption of the cAMP–
PKA–CREB signaling cascade specifically in the PFC (but not in 
the dorsal HPC) has an essential role in promoting long-term neu-
roadaptive changes accompanying persistent behavioral changes 
during withdrawal from chronic alcohol intake. Interestingly, 
early pioneering work in our laboratory emphasized a key role 
for PKA–CREB signaling as a sustained “molecular switch” 
that gradually converts acute “drug” responses into relatively 
stable adaptations that contribute to drug and alcohol addiction-
mediated long-lasting neural and behavioral plasticity. Under 
conditions of drug- and food-reinforced behavior, drug-induced 
reward impaired spatial discrimination learning in a Y-maze task 
and caused drastic decreases in pCREB and downstream target 
c-Fos expression in the dorsal HPC and the PFC while sparing 
the cued version of the task and pCREB in the dorsal striatum 
in mice (98). Further, pharmacological blockade of cAMP–PKA 
cascade into the striatum before training normalized CREB activ-
ity within the HPC–PFC circuit and, as subsequently, prevented 
the drug-induced modulation of multiple memory systems.
Emerging evidence indicates that brain region-specific altera-
tion of CREB signaling is also an important regulator involved in 
depression-like behavior that emerges during abstinence follow-
ing alcohol drinking. As a key symptom of clinical depression, 
anhedonia reflects reduced interest in enjoying pleasure-seeking 
behavior and plays a key role in relapse (99, 100) and in the perpetu-
ation of excessive alcohol consumption in dependent individuals 
(101). Important clinical evidence clearly demonstrated that the 
persistence and intensity of some behavioral withdrawal symp-
toms positively correlated with anhedonia scales in detoxified 
alcohol-dependent subjects (102), extending previous findings 
of strong correlation between anhedonia and substance-related 
symptoms particularly in detoxified opiate-dependent subjects 
(103). The presence of depression-related behavioral phenotypes 
during protracted abstinence was also reported in rodent models 
(104–106). In mice undergoing 2  weeks of abstinence from 
chronic alcohol consumption, the persistent increase in plasma 
corticosterone response and upregulation of GR expression 
correlated with the development of depressive-like phenotypes, 
including anhedonia and helplessness (105), and reduced hip-
pocampal neurogenesis (104). Further, there are several lines of 
evidence that suggest that downregulation of BDNF–TrKB–CREB 
signaling pathway may serve as a common link between the 
development of alcohol-induced depression-like symptoms and 
reduced hippocampal neurogenesis (104, 105, 107, 108). Finally, 
since enhancing the BDNF–CREB activity through pharmaco-
logical treatments with various classes of antidepressant drugs 
or environmental enrichment abolished the alcohol-induced 
anhedonia and depressive behaviors seen during protracted 
abstinence (104, 107, 108), supporting the hypothesis that 
BDNF–CREB signaling pathway may be a potential therapeutic 
target for interventions in alcoholism–depression coincidence.
ALCOHOL ALTeRS THe BALANCe 
BeTweeN HiSTONe ACeTYLATiON: 
DeACeTYLATiON
Equally important for providing precise, long-lasting changes in 
brain function associated with alcohol intake are histone modi-
fications, which exert lasting control over transcriptional activity 
of target genes through modifications of the chromatin structure 
and function that make the DNA less or more accessible to tran-
scription factors and enzymes. The basic unit of chromatin, the 
nucleosome, is a histone octamer wrapped by approximately 147 
base pairs of DNA. Each core histone (H2A, H2B, H3, and H4) 
has a highly conserved amino (N)-terminal tail, which is subject 
through a range of posttranslational modification (PTM) marks 
at distinct residues/sites including acetylation and methylation 
of lysine residues and phosphorylation of serine residues (109). 
Histones acetylation and phosphorylation are associated with 
transcriptional activation, whereas histone methylation reflects 
both transcriptional activation and repression depending on 
the specific site and context of the modification. An important 
feature of histone PTMs is that they can influence each other in 
a synergistic or antagonistic manner, leading to a complex “his-
tone code” (110). Of these histone PTMs, histone acetylation is 
the most widely investigated in terms of epigenetic mechanisms 
underlying region-specific changes in brain gene networks 
required for long-term memory processes. Many rodent studies 
have detailed how different learning paradigms trigger distinct 
histone acetylation patterns in the brain, which are accompanied 
by region-, task-, and age-specific changes in memory-associated 
genes [for reviews, see Ref. (111–115)]. For instance, increased 
acetylation of histones, H3 and H4, occurred in the dorsal 
HPC or the dorsal striatum, depending on whether mice were 
subjected to a spatial or cued training in the water maze task, 
respectively (116, 117).
The degree of histone acetylation/deacetylation is finely 
orchestrated by dynamic balance of antagonistic enzymes that 
“write” (HATs) and “erase” [histone deacetylases (HDACs)] 
acetylation sites (113, 118–121). Systemic administration of 
HDAC inhibitors (HDACi), such as sodium butyrate (NaB) 
or trichostatin A (TSA), can improve memory formation and 
also prevent or reverse cognitive impairments associated with 
normal and pathological aging. However, this enhancing effect 
of HDACi on HPC-dependent memory required accurate CREB 
activity (116, 117, 122). Furthermore, infusing HDACi directly 
to the HPC was not only effective in promoting HPC-dependent 
learning and memory processes but can also influence relative use 
of multiple memory processes by affecting transcriptional events 
within subcortical and PFC cortical structures (116, 123).
A growing set of studies in both humans and animals have 
indicated that alcohol exposure causes widespread, dynamic 
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changes of histone acetylation patterns, and thereby dysregula-
tion in gene expression profiles across multiple brain regions 
(28, 124–126). Most of the studies have focused on the two 
histones H3 and H4 acetylation and chromatin-related events 
within the PFC, the HPC, and the AMG. In mouse and rat 
brain, studies reported that alcohol’s effects on histone acetyla-
tion patterns depend on the alcohol treatment paradigm, the 
timing of alcohol exposure or withdrawal, and brain structures 
examined, and even within a structure, alcohol can affect dif-
ferently subregions. For example, work from Pandey’s lab has 
shown that anxiolytic-like responses caused by acute ethanol i.p. 
injection were accompanied by increased HAT CBP activity and 
associated increased acetylation of histone H3 at lysine 9 and 
histone H4 at lysine 8 (H3K9 and H4K8, respectively) leading 
to rapid elevation of NPY (mRNA and protein level) specifically 
in the central and medial, but not the basolateral amygdaloid, 
nuclei (125). The same group observed that a 2-week ethanol 
exposure followed by acute ethanol withdrawal (24 h) switches 
alcohol’s effect to anxiogenic-like responses, effects that involve 
a shift from HDAC hypoactivity to HDAC hyperactivity and 
subsequently decreased histone acetylation and transcriptional 
repression of NPY function in the two AMG nuclei (125, 127, 
128). Correcting histone acetylation deficits in the AMG via 
administration of the pan HDACi TSA can reverse the rapid 
tolerance to the anxiolytic effects of ethanol (128) and prevent 
the development of alcohol withdrawal-related anxiety in rat 
(125). Alcohol-induced neuroadaptation in the AMG also impli-
cated deficits of BDNF activity and its target [activity-regulated 
cytoskeleton-associated protein (Arc)], two key signaling 
factors involved in synaptic transmission and plasticity. While 
acute ethanol exposure caused an upregulation of BDNF–Arc 
signaling pathway and subsequently increased dendritic spine 
densities in the central and medial AMG nuclei, withdrawal 
from prolonged ethanol exposure or binge ethanol consump-
tion potently inhibited BDNF and Arc expression and reduced 
dendritic arborization in these nuclei and other regions, leading 
to increased anxiety-like and drinking behaviors (66, 129, 130). 
Importantly, these long-lasting adaptive changes associated with 
alcohol dependence were reversed upon treatment with the 
HDACi TSA (61, 128–130). In another study by Moonat and col-
leagues (61) examining the role of HDAC2 in the development 
of alcohol dependence, investigators found lower baseline BDNF 
protein levels in the AMG (and also the bed nucleus of stria 
terminalis) of alcohol-preferring rats, a well-established model 
used to study the genetic predisposition to alcoholism (131), 
relative to the low-drinking NP rats. In addition, innate HDAC2 
overexpression and decreased H3K9 acetylation in the central 
nucleus of alcohol-preferring rats correlated with low levels of 
BDNF, Arc, and NPY and was accompanied with high levels of 
anxiety-like and alcohol-drinking behaviors. These HDAC2-
associated molecular and behavioral deficits were rescued via 
specific knockdown of HDAC2 expression either by direct infu-
sion of small interfering RNA (siRNA) against HDAC2 into the 
central AMG nucleus (61, 66) or by TSA treatment (127, 130, 
132). Collectively, these observations raised the possibility that 
adaptive epigenetic changes involving HDACs, and in particular 
HDAC2, in the AMG may be important regulatory mechanisms 
that underlie expression of genes implicated in the development 
and pathogenesis of alcohol dependence.
Using a chronic intermittent ethanol exposure model, a robust 
H3K9 hyperacetylation was seen in the AMG and cortical areas 
of rats, which displayed motivation to self-administer ethanol 
after a 6-h withdrawal period, compared with non-dependent 
rats (133). Treatment with the HDACi NaB or MS-275 (i.p. or 
i.c.v.) was able to counteract the effects of alcohol in dependent 
rats but not in non-dependent rats. Treatment with NaB, when 
administrated prior to ethanol self-administration, was also 
able to reverse H3K9 hyperacetylation and counteract excessive 
alcohol intake and relapse in alcohol-dependent rats. In order to 
identify brain region-specific regulatory molecular (epigenetic) 
signatures potentially involved in adaptive processes that lead to 
alcohol tolerance and dependence, Smith and colleagues (134) 
recently examined brain regional expression network responses 
to acute (0–8 h) and late (72 h to 7 days) withdrawal from chronic 
intermittent ethanol exposure in mice. Remarkably, the authors 
showed that neuroinflammatory responsive genes can be seen 
across all brain regions at 0–8 h after the beginning of alcohol 
withdrawal, while sustained over-representation for subset 
groups of genes related to neurodevelopment and synaptic plas-
ticity (such as Bdnf) and to histone acetylation (such as HDAC4 
and HDAC6) and histone/DNA methylation are found at 3- to 
7-day-withdrawal periods specifically in the PFC and the HPC. 
These results illustrate how transient and persistent histone acety-
lation changes could serve as a key mechanism for tight regula-
tion of the expression of large sets of genes within specific brain 
regions of animals predisposed to excessive ethanol drinking or 
exposed to protracted abstinence. A functional disconnection 
of the CeA–PFC circuit during abstinence (72 h) and renewed 
access to alcohol has been recently implicated in long-lasting 
PFC-dependent cognitive dysfunction and the development of 
anxiety-like behavior, and more specifically, the resulting PFC 
hypofunction was shown to facilitate the transition from moder-
ate to excessive and uncontrolled alcohol intake in rats (46).
Persistent changes of the HAT CBP activity and H4 acetyla-
tion were observed in the frontal cortex of C57BL/6 mice given 
5-month chronic alcohol consumption followed by a 15-day 
withdrawal period (135). In that study, withdrawal-associated H4 
hypoacetylation correlated with neuroinflammatory damage and 
the persistently altered memory and anxiety-related behaviors. 
Nonetheless, these changes were absent in mice lacking the Toll-
like receptor 4 (TLR4) that have undergone the same treatment, 
suggesting a critical role for TLR4-mediated epigenetic modifi-
cations in mediating long-lasting deleterious effects of chronic 
alcohol on PFC-dependent behaviors (135). This is in line with 
findings in our laboratory showing a robust decrease in histone 
H4 acetylation in the medial PFC of C57/BL mice at 1 week after 
withdrawal from chronic alcohol consumption; this decrease was 
maintained for at least 6 weeks after alcohol withdrawal and corre-
lated with the persistently impairment of working memory noted 
during abstinence (31, 47). Alcohol’s effects on H4 acetylation 
closely paralleled effects on CREB activation in the PFC. Further, 
systemic delivery of corticosterone inhibitor metyrapone or local 
intra-PFC blockade of MRs (via spironolactone) or GRs (via 






















































FiGURe 1 | endocrine and molecular events that are associated with long-lasting prefrontal cortex (PFC)-based working memory impairment during 
withdrawal from prolonged ethanol consumption. (Left) in C57BL/6 mice, chronic ethanol consumption (6 months) followed by a 6-week withdrawal period 
causes excessive peak corticosterone (CORT) response, specifically in the PFC that lasts for several weeks. Protracted withdrawal also produces long-lasting 
deficits in pCREB and histone H4 acetylation levels in the PFC along with enduring working memory impairments. (Red) pharmacological glucocorticoid blockade in 
the PFC through bilateral infusion of drugs that diminish corticosteroid receptors [mineralocorticoid (spironolactone; MR) or glucocorticoid (mifepristone; GR)] activity 
as well as pharmacological elevation of cAMP–PKA-mediated signaling cascade through bilateral infusion of the cAMP analog Sp-cAMPS into the PFC fully prevent 
long-lasting alcohol-related endocrine, molecular, and behavioral changes. Adapted from Ref. (31, 47).
7
Mons and Beracochea Epigenetic Adaptation to Alcohol
Frontiers in Psychiatry | www.frontiersin.org October 2016 | Volume 7 | Article 165
and H4 acetylation levels in the PFC and alleviated working 
memory deficits associated with alcohol withdrawal (31). Thus, 
these findings suggest that long-lasting glucocorticoid-induced 
neuroadaptive changes in CREB and H4 acetylation in the PFC 
may be involved in the enduring working memory impairments 
caused by prolonged alcohol consumption and withdrawal. 
Cumulative evidence indicates that structural and functional 
integrity of the HPC was also compromised in rats after pro-
longed alcohol exposure and even greatest alterations were found 
after cessation of alcohol exposure (136–138). Prolonged ethanol 
intake caused enduring deficits in HPC-dependent spatial refer-
ence memory in the water maze (138–140). Chronic ethanol 
treatment also caused long-lasting decrease of histone acetylation 
in the dorsal HPC. However, contrary to the PFC where there 
was strong relationship between alcohol-induced decrease of H4 
acetylation and long-lasting working memory impairments, H4 
acetylation in the HPC (the CA1 region) was decreased in behav-
iorally “unimpaired” alcohol-treated mice and even continued to 
decrease in “impaired” withdrawal-treated mice, compared with 
water-treated mice (31, 47). However, the drugs that prevented 
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alcohol’s effects in the PFC did not rescue alcohol’s effects on HPC 
function, underscoring a region-specific influence of regulatory 
epigenetic signature on adaptive processes that lead to alcohol 
tolerance and dependence.
ALCOHOL AND HiSTONe H3 
MODiFiCATiON CROSS TALKS
Ethanol’s effects on histone H3 phosphorylation at serine 10 
(H3ser10phos) and concurrent H3 phosphoacetylation are of 
particular interest as their rapid elevation is critical for leaning/
memory-associated induction of immediate-early genes (e.g., 
c-fos and egr-1) (141–143), an effect shown to mediate adaptive 
responses to psychology stressful events such as forced swimming 
or novelty stress paradigm exposure (142–145). In rats, acute 
ethanol dose dependently alters the number of H3ser10phos 
in the dentate granular cells of the HPC, and these changes are 
paralleled by changes in c-fos protein expression (146). The 
same group has shown that, in ethanol-dependent rats, both 
H3ser10phos and c-fos levels are reduced in dentate granule cells 
during excessive alcohol intake, while opposite effects are evident 
at withdrawal peak in the HPC. Elevation of H3ser10phos and 
histone H3 phosphoacetylation is achieved through a direct 
interaction of the GR with [mitogen- and stress-activated pro-
tein kinase 1 (MSK1)] and ETS-domain protein Elk-1 that are 
downstream of the ERK/MAPK signaling cascade (143, 145, 
147, 148). Conversely, nuclear type 1 protein phosphatase (PP1), 
a nuclear protein Ser/Thr phosphatase that acts as a universal 
negative regulator of memory and synaptic plasticity, interfered 
with H3Ser10phos in several brain areas such as the HPC and the 
AMG (149–152).
Combinatorial modifications of acetylated H3 and histone 
H3 lysine 4 trimethylation (H3K4me3) have been implicated in 
long-term adaptive changes in the HPC resulting from prolonged 
alcohol intake (126, 153). Using a 3-week mouse model of chronic 
ethanol consumption, Stragier and colleagues (154) recently 
reported that ethanol-induced BDNF-mediated neuroplastic 
changes in the HPC are controlled by combinatorial modifica-
tions of acetylated H3 and H3K4me3 around individual Bdnf 
gene promoters in dorsal CA3 region and the dentate gyrus and 
by decreased Bdnf DNA methylation in CA1–CA3 regions of 
the HPC. These ethanol-induced changes were associated with a 
deficit in HPC-dependent (contextual fear and novel recognition 
object) memory while sparing AMG-based cued fear memory. 
Chronic intermittent ethanol vapor exposure followed by 
2–5 days of abstinence robustly and selectively increased histone 
H3K9 acetylation and DNA demethylation in PFC neurons with 
a parallel decrease of H3K9 methylation repressive mark as well 
as a downregulation of a set of histone methyltransferases (HMT) 
(155, 156). These changes mostly occurred after ethanol removal 
and contributed to the development of physical dependence on 
alcohol through an adaptive long-lasting upregulation of the 
NMDA receptor 2B (NR2B) gene expression (155). Moreover, 
systemic treatment with TSA during ethanol exposure increased 
H3K9 acetylation at the NR2B promoter in PFC neurons and 
potentiated voluntary ethanol consumption (157). Together, these 
data suggest that persistent upregulation of the NR2B-containing 
NMDA receptors through deregulation of the balance between 
histone H3K9 acetylation and methylation states in the PFC may 
act as a potentially important contributor to the development of 
alcohol dependence.
CONCLUDiNG ReMARKS
This review summarizes recent advances in our comprehension 
of endocrine, epigenetic, and transcriptional changes that serve 
as determining factors in controlling alcohol-associated changes 
in the expression of gene networks and behavior and play a 
central role in the regulation of alcohol dependence, withdrawal, 
and relapse (Figure 1). Most of the studies conducted thus far 
focused mainly on epigenetic and transcriptional regulation 
of adaptive responses to acute and chronic alcohol that occur 
within a single brain region (mostly the AMG). This review 
highlights new evidence from clinical and preclinical studies on 
how long-term adaptations arising from disruption of the fine 
coordination of highly interconnected brain structures within 
a circuit, including, but not limited to, the PFC, the HPC, and 
the AMG, may contribute to excessive alcohol consumption 
and alcohol dependence as well as behavior impairments. The 
findings reviewed in this article support the view that brain 
region- and cell type-specific histone acetylation modifica-
tion (both in terms of global/genome-wide changes as well as 
promoter-specific changes) is a key mechanism underlying 
anxiety-like and alcohol-drinking behaviors. Thus, treatments 
designed to counteract alcohol-associated epigenetic changes 
may be promising targets for novel medications in the treatment 
of alcoholism.
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